Hematological unit invasive aspergillosis epidemiology

Yoriko Maehara, Yoji Nagasaki, Masako Kadowaki, Yoshihiro Eriguchi, Noriko Miyake, Yujiro Uchida, Koji Nagafuji, Nobuyuki Shimono

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Invasive aspergillosis (IA) is a major cause of morbidity and mortality among the immunocompromised, especially those undergoing hematopoietic stem cell transplantation. With spore inhalation the usual infection route, such subjects must be protected from environmental spore contamination, necessitating measures such as high-efficiency particulate air (HEPA) filtration. In April 2006, we implemented a new transplantation unit with HEPA filtration. We retrospectively evaluated its efficacy for hospitalized transplantation unit subjects whose sera were tested for aspergillus galactomannan antigen between April 2004 and March 2007. Subjects numbered 265 (973 samples) categorized as definite, probable, or possible. The earliest IA onset date was when symptoms, positive radiological findings, or positive galactomannan antigen tests occurred, based on revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) definitions. We classified cases when IA occurred over 10 days after admission as hospital-acquired. No such cases were detected after November 2005 and IA incidence decreased significantly after the new unit began being used. Results suggest that the new unit and HEPA filtration helped eliminate nosocomial IA.

Original languageEnglish
Pages (from-to)176-181
Number of pages6
JournalKansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Volume84
Issue number2
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Aspergillosis
Epidemiology
Air
Spores
National Institute of Allergy and Infectious Diseases (U.S.)
Transplantation
Antigens
Sodium Glutamate
Mycoses
Hematopoietic Stem Cell Transplantation
Aspergillus
Inhalation
Organizations
Morbidity
Mortality
Incidence
Infection
Serum
Research
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hematological unit invasive aspergillosis epidemiology. / Maehara, Yoriko; Nagasaki, Yoji; Kadowaki, Masako; Eriguchi, Yoshihiro; Miyake, Noriko; Uchida, Yujiro; Nagafuji, Koji; Shimono, Nobuyuki.

In: Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases, Vol. 84, No. 2, 01.01.2010, p. 176-181.

Research output: Contribution to journalArticle

Maehara, Yoriko ; Nagasaki, Yoji ; Kadowaki, Masako ; Eriguchi, Yoshihiro ; Miyake, Noriko ; Uchida, Yujiro ; Nagafuji, Koji ; Shimono, Nobuyuki. / Hematological unit invasive aspergillosis epidemiology. In: Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 2010 ; Vol. 84, No. 2. pp. 176-181.
@article{e3ee5c276ea74320abff2b83fefd26bd,
title = "Hematological unit invasive aspergillosis epidemiology",
abstract = "Invasive aspergillosis (IA) is a major cause of morbidity and mortality among the immunocompromised, especially those undergoing hematopoietic stem cell transplantation. With spore inhalation the usual infection route, such subjects must be protected from environmental spore contamination, necessitating measures such as high-efficiency particulate air (HEPA) filtration. In April 2006, we implemented a new transplantation unit with HEPA filtration. We retrospectively evaluated its efficacy for hospitalized transplantation unit subjects whose sera were tested for aspergillus galactomannan antigen between April 2004 and March 2007. Subjects numbered 265 (973 samples) categorized as definite, probable, or possible. The earliest IA onset date was when symptoms, positive radiological findings, or positive galactomannan antigen tests occurred, based on revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) definitions. We classified cases when IA occurred over 10 days after admission as hospital-acquired. No such cases were detected after November 2005 and IA incidence decreased significantly after the new unit began being used. Results suggest that the new unit and HEPA filtration helped eliminate nosocomial IA.",
author = "Yoriko Maehara and Yoji Nagasaki and Masako Kadowaki and Yoshihiro Eriguchi and Noriko Miyake and Yujiro Uchida and Koji Nagafuji and Nobuyuki Shimono",
year = "2010",
month = "1",
day = "1",
doi = "10.11150/kansenshogakuzasshi.84.176",
language = "English",
volume = "84",
pages = "176--181",
journal = "Nippon Densenbyo Gakkai zasshi",
issn = "0387-5911",
publisher = "Nihon Kansensho Gakkai",
number = "2",

}

TY - JOUR

T1 - Hematological unit invasive aspergillosis epidemiology

AU - Maehara, Yoriko

AU - Nagasaki, Yoji

AU - Kadowaki, Masako

AU - Eriguchi, Yoshihiro

AU - Miyake, Noriko

AU - Uchida, Yujiro

AU - Nagafuji, Koji

AU - Shimono, Nobuyuki

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Invasive aspergillosis (IA) is a major cause of morbidity and mortality among the immunocompromised, especially those undergoing hematopoietic stem cell transplantation. With spore inhalation the usual infection route, such subjects must be protected from environmental spore contamination, necessitating measures such as high-efficiency particulate air (HEPA) filtration. In April 2006, we implemented a new transplantation unit with HEPA filtration. We retrospectively evaluated its efficacy for hospitalized transplantation unit subjects whose sera were tested for aspergillus galactomannan antigen between April 2004 and March 2007. Subjects numbered 265 (973 samples) categorized as definite, probable, or possible. The earliest IA onset date was when symptoms, positive radiological findings, or positive galactomannan antigen tests occurred, based on revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) definitions. We classified cases when IA occurred over 10 days after admission as hospital-acquired. No such cases were detected after November 2005 and IA incidence decreased significantly after the new unit began being used. Results suggest that the new unit and HEPA filtration helped eliminate nosocomial IA.

AB - Invasive aspergillosis (IA) is a major cause of morbidity and mortality among the immunocompromised, especially those undergoing hematopoietic stem cell transplantation. With spore inhalation the usual infection route, such subjects must be protected from environmental spore contamination, necessitating measures such as high-efficiency particulate air (HEPA) filtration. In April 2006, we implemented a new transplantation unit with HEPA filtration. We retrospectively evaluated its efficacy for hospitalized transplantation unit subjects whose sera were tested for aspergillus galactomannan antigen between April 2004 and March 2007. Subjects numbered 265 (973 samples) categorized as definite, probable, or possible. The earliest IA onset date was when symptoms, positive radiological findings, or positive galactomannan antigen tests occurred, based on revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) definitions. We classified cases when IA occurred over 10 days after admission as hospital-acquired. No such cases were detected after November 2005 and IA incidence decreased significantly after the new unit began being used. Results suggest that the new unit and HEPA filtration helped eliminate nosocomial IA.

UR - http://www.scopus.com/inward/record.url?scp=77952779231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952779231&partnerID=8YFLogxK

U2 - 10.11150/kansenshogakuzasshi.84.176

DO - 10.11150/kansenshogakuzasshi.84.176

M3 - Article

C2 - 20420162

AN - SCOPUS:77952779231

VL - 84

SP - 176

EP - 181

JO - Nippon Densenbyo Gakkai zasshi

JF - Nippon Densenbyo Gakkai zasshi

SN - 0387-5911

IS - 2

ER -